TommyBoyTrader

[Plowmaster]

Understand the situation $BWVI is in and you will understand what an amazing scenario this is.

Massive L2 shift last week, momentum moving to FINRA completing the ticker change for Psycheceutical.com from being filed 5.5 Months ago. An amazing company in the psycheceutical space, great IP and an incredible massively accomplished management team. Kevin Harrington (Shark Tank) a primary investor and advisor. Dr. Bailes (20+ NFL Neurosurgeon, top national ranked, 2016 film 'Concussion' after him), and Mike Zappy Zapolin, successful wall street and hollywood, Great IP with the drug delivery system.

The industry is more than primed for psycheceutical with massive evidence of the regulatory pathways becoming more and more clear. Just Today even Biden stated federal support for development and last week the DEA changed their stance.

Once we complete the FINRA ticker change, we will get listed in the industry stock lists and the discovery will be amazing. Investors waiting to get in on the change as well.

The float is super low, hasn't changed for a long time, the OS is lower than almost all the other Psycheceutical stocks, and the float is very locked up.

Do yourself a favor go to the deep due diligence on $BWVI.

More progressive news for #psychedelicmedicine as a letter from @samhsagov to @RepDean agrees that "we must explore the potential of psychedelic-assisted therapies to address this crisis."@theintercept: https://t.co/WExwJYhPZi #mentalhealth

— Psycheceutical (@psycheceutical) August 1, 2022

What a week for #psychedelicmedicine! Could this new reversal from @DEAHQ set the precedent needed to review and potentially remove other psychedelic compounds from Schedule 1 classification?

Via @Microdosehq: https://t.co/3OogiBjjTQ#MentalHealthMatters #Progress

— Psycheceutical (@psycheceutical) July 29, 2022

https://www.politico.com/news/2022/07/29/legalizing-the-trip-one-shroom-advocates-playbook-00048207

Psilocybin:

$6.9 billion is the estimated size of the global pharmaceutical psilocybin market by 2027, according to @DBMROfficial

— Psychedelic Finance (@Psych_Fin) July 28, 2022